UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q ______________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35776 ______________________________________ A ...

Acasti Pharma Inc. (NASDAQ:ACST) Q2 2023 Earnings Conference Call November 14, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Jan D'Alvise - President & CEO Brian Ford - CFO Prashant Kohli - Chief Commercial Officer Conference Call Participants Leland Gershell - Oppenheimer Sahil Kazmi - B. Riley Securities Operator Good day, and welcome to the Acasti Pharma Second Quarter 2023 Earnings Event Call. All participants will be in listen-only mode. [Operator Instructions] After today's pr ...

Acasti Pharma Inc. (NASDAQ:ACST) Q1 2023 Earnings Conference Call August 11, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, Investor Relations Jan D'Alvise - President & Chief Executive Officer Brian Ford - Chief Financial Officer Pierre Lemieux - Chief Operating & Scientific Officer Prashant Kohli - Vice President, Commercial Operations Conference Call Participants Leland Gershell - Oppenheimer Operator Good day, and welcome to the Acasti Pharma's First Quarter Fiscal Year 2023 Financi ...

Acasti Pharma, Inc. (NASDAQ:ACST) Q4 2022 Earnings Conference Call June 21, 2022 1:00 PM ET Company Participants Robert Blum - Investor Relations Jan D'Alvise - President and Chief Executive Officer Brian Ford - Chief Financial Officer Monique Champagne - Vice President, Clinical Affairs Conference Call Participants Leland Gershell - Oppenheimer Operator Good day, and welcome to the Acasti Pharma Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen-only m ...

Acasti Pharma Inc. (NASDAQ:ACST) Q3 2021 Earnings Conference Call February 14, 2022 1:00 PM ET Company Participants David Waldman - Investor Relations Jan D’Alvise - President and Chief Executive Officer Brian Ford - Chief Financial Officer George Kottayil - Chief Operating Officer US Conference Call Participants Sahil Kazmi - B. Riley Securities Alexandra Heller - Oppenheimer Operator Good day, ladies and gentlemen, and welcome to the Acasti Pharma Third Quarter Fiscal 2022, Business Update Conference Cal ...